You are here

Home » Reports

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 90 results
 
  • Record 1 TO 90

  1. Technology Supports for Home Health Care Providers

    SBC: ABLELINK TECHNOLOGIES INC            Topic: N/A

    Specialized computer-based health care support technology has great potential for addressing the needs of family home health care providers in providing care to seniors. The proposed system will be designed to provide simplified multi-media instruction

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  2. Removal of Arsenic and Heavy Metals from Drinking Water

    SBC: ADA TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): In 2001 the US EPA lowered the maximum contaminant level for arsenic in drinking water from 50 ppb to 10 ppb, based on studies indicating the lower limit would prevent a significant number of cancer deaths and other il

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health

  3. Dental Waterline Cleansing System

    SBC: ADA TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION: The overall objective of this multiphase SBIR project is to develop and market an economical Dental waterline system that prevents biofilm formation and growth. Once a biofilm forms on a wetted surface, microorganisms are continuously release

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  4. A Child's Body-Powered Prehensor with Adaptive Grasp

    SBC: ADA TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): At present, children with upper-limb deficiencies have few choices of prosthetic prehensors available to them. For many of these children, body-powered devices offer a better--or in some cases the only--rehabilitat

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  5. Prosthetic Shoulder with User-Controlled Flexion

    SBC: ADA TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Existing prosthetic shoulder modules control humeral flexion either by applying light frictional drag or by operating in one of two discrete user-selectable modes: free-swing or fully locked. In many cases, limite

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  6. Inhalable IgG Synthesis For Influenza Immunoprophylaxis

    SBC: AKTIV-DRY            Topic: N/A

    DESCRIPTION (provided by applicant): This Phase I SBIR proposal is the first step in the development of inhalable IgG microparticles for immunoprophylaxis against Influenza A, a category C Priority Pathogen. In Phase I, Aktiv-Dry will simultaneously s

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  7. Hepatitis C Virus Protein Microarrays

    SBC: Avidity, LLC            Topic: N/A

    DESCRIPTION (provided by investigator): Hepatitis C virus (HCV) is the leading cause of chronic liver diseases such as cirrhosis and hepatocellular carcinoma, and liver transplantation worldwide. The co-infection of HCV with other viruses (e.g. HIV) i

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health

  8. Long-Acting Endostatin for Treating Cancer

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    DESCRIPTION (provided by applicant): Endostatin is a 20 kDa non-glycosylated protein that is a specific inhibitor of endothelial proliferation and a potent anti-angiogenesis agent. The therapeutic effects of endostatin have been difficult to evaluate f

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health

  9. Long-Acting Beta Interferon for Multiple Scierosis

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    DESCRIPTION (provided by applicant): B-Interferon is a fibroblast-derived cytokine that exhibits antiviral, anti-proliferative and immunomodulatory effects on many cell types. Recombinant human B-interferon has proven effective in treating Multiple Scl

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health

  10. Long-Acting VEGF Binding Proteins for Treating Cancer

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    DESCRIPTION (provided by applicant): Vascular endothelial growth factor (VEGF) has been identified as a key mediator of tumor angiogenesis and has emerged as the single most commonly upregulated angiogenic factor in both grafted and naturally occurri

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government